Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns
Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns
Status: Enrolling
Updated:  12/5/2016
University of South Florida, Tampa General Hospital
mi
from
Tampa, FL
ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns
Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns
Status: Enrolling
Updated: 12/5/2016
University of South Florida, Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns
Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns
Status: Enrolling
Updated:  12/5/2016
Loyola University Medical Center
mi
from
Maywood, IL
ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns
Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns
Status: Enrolling
Updated: 12/5/2016
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns
Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns
Status: Enrolling
Updated:  12/5/2016
University of Kentucky Chandler Medical Center
mi
from
Lexington, KY
ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns
Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns
Status: Enrolling
Updated: 12/5/2016
University of Kentucky Chandler Medical Center
mi
from
Lexington, KY
Click here to add this to my saved trials
ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns
Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns
Status: Enrolling
Updated:  12/5/2016
Johns Hopkins Burn Center
mi
from
Baltimore, MD
ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns
Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns
Status: Enrolling
Updated: 12/5/2016
Johns Hopkins Burn Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns
Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns
Status: Enrolling
Updated:  12/5/2016
Brigham and Women's Hosp
mi
from
Boston, MA
ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns
Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns
Status: Enrolling
Updated: 12/5/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns
Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns
Status: Enrolling
Updated:  12/5/2016
University of Missouri Health Care
mi
from
Columbia, MO
ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns
Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns
Status: Enrolling
Updated: 12/5/2016
University of Missouri Health Care
mi
from
Columbia, MO
Click here to add this to my saved trials
ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns
Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns
Status: Enrolling
Updated:  12/5/2016
Acute & Critical Care Surgery Barnes Jewish Hospital, Washington University Medical Center
mi
from
St. Louis, MO
ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns
Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns
Status: Enrolling
Updated: 12/5/2016
Acute & Critical Care Surgery Barnes Jewish Hospital, Washington University Medical Center
mi
from
St. Louis, MO
Click here to add this to my saved trials
ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns
Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns
Status: Enrolling
Updated:  12/5/2016
University of Rochester
mi
from
Rochester, NY
ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns
Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns
Status: Enrolling
Updated: 12/5/2016
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns
Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns
Status: Enrolling
Updated:  12/5/2016
MetroHealth Med Ctr
mi
from
Cleveland, OH
ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns
Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns
Status: Enrolling
Updated: 12/5/2016
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns
Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns
Status: Enrolling
Updated:  12/5/2016
Western Pennsylvania Hospital
mi
from
Pittsburgh, PA
ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns
Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns
Status: Enrolling
Updated: 12/5/2016
Western Pennsylvania Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns
Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns
Status: Enrolling
Updated:  12/5/2016
John S. Dunn Sr. Burn Center
mi
from
Houston, TX
ACCS (Amnion-derived Cellular Cytokine Solution) Versus Standard Care In Treating Partial Thickness Burns
Phase I/II Randomized Blinded Safety, Dose-determining Efficacy Trial Comparing Amnion-derived Cellular Cytokine Solution in 3 Different Regimens With Standard Care 0.9% Sodium Chloride in the Topical Treatment of Partial-thickness Burns
Status: Enrolling
Updated: 12/5/2016
John S. Dunn Sr. Burn Center
mi
from
Houston, TX
Click here to add this to my saved trials
Assessment of Bone Density and Bone Turnover Markers in Patients With Down Syndrome and Comparison to the Ts65Dn Model
Assessment of Bone Density and Bone Turnover Markers in Patients With Down Syndrome and Comparison to the Ts65Dn Model
Status: Enrolling
Updated:  12/6/2016
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Assessment of Bone Density and Bone Turnover Markers in Patients With Down Syndrome and Comparison to the Ts65Dn Model
Assessment of Bone Density and Bone Turnover Markers in Patients With Down Syndrome and Comparison to the Ts65Dn Model
Status: Enrolling
Updated: 12/6/2016
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
An Exploratory Trial of Ketamine for the Treatment of Rett Syndrome
Ketamine for the Treatment of Rett Syndrome: An Exploratory Trial
Status: Enrolling
Updated:  12/15/2016
Cleveland Clinic
mi
from
Cleveland, OH
An Exploratory Trial of Ketamine for the Treatment of Rett Syndrome
Ketamine for the Treatment of Rett Syndrome: An Exploratory Trial
Status: Enrolling
Updated: 12/15/2016
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
Status: Enrolling
Updated:  12/19/2016
Queen's Medical Center
mi
from
Honolulu, HI
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
Status: Enrolling
Updated: 12/19/2016
Queen's Medical Center
mi
from
Honolulu, HI
Click here to add this to my saved trials
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
Status: Enrolling
Updated:  12/19/2016
Johns Hopkins University
mi
from
Baltimore, MD
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
Status: Enrolling
Updated: 12/19/2016
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
Status: Enrolling
Updated:  12/19/2016
New York Presbyterian Hospital-Weill Cornell Medical Center
mi
from
New York, NY
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
Status: Enrolling
Updated: 12/19/2016
New York Presbyterian Hospital-Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
Status: Enrolling
Updated:  12/19/2016
Oregon Health and Science University
mi
from
Portland, OR
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
Status: Enrolling
Updated: 12/19/2016
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
Status: Enrolling
Updated:  12/19/2016
University of Pennsylvania School of Medicine
mi
from
Philadelphia, PA
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
Status: Enrolling
Updated: 12/19/2016
University of Pennsylvania School of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
Status: Enrolling
Updated:  12/19/2016
University of Texas Medical School in Houston
mi
from
Houston, TX
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
Status: Enrolling
Updated: 12/19/2016
University of Texas Medical School in Houston
mi
from
Houston, TX
Click here to add this to my saved trials
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
Status: Enrolling
Updated:  12/19/2016
Baylor College of Medicine
mi
from
Houston, TX
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
Status: Enrolling
Updated: 12/19/2016
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors
Feasibility of Omega-3 Supplementation for Cancer-Related Fatigue
Status: Enrolling
Updated:  1/3/2017
Wichita NCORP
mi
from
Wichita, KA
Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors
Feasibility of Omega-3 Supplementation for Cancer-Related Fatigue
Status: Enrolling
Updated: 1/3/2017
Wichita NCORP
mi
from
Wichita, KA
Click here to add this to my saved trials
Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors
Feasibility of Omega-3 Supplementation for Cancer-Related Fatigue
Status: Enrolling
Updated:  1/3/2017
Cancer Research Consortium of West Michigan
mi
from
Grand Rapids, MI
Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors
Feasibility of Omega-3 Supplementation for Cancer-Related Fatigue
Status: Enrolling
Updated: 1/3/2017
Cancer Research Consortium of West Michigan
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors
Feasibility of Omega-3 Supplementation for Cancer-Related Fatigue
Status: Enrolling
Updated:  1/3/2017
University of Rochester NCORP Research Base
mi
from
Rochester, NY
Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors
Feasibility of Omega-3 Supplementation for Cancer-Related Fatigue
Status: Enrolling
Updated: 1/3/2017
University of Rochester NCORP Research Base
mi
from
Rochester, NY
Click here to add this to my saved trials
Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors
Feasibility of Omega-3 Supplementation for Cancer-Related Fatigue
Status: Enrolling
Updated:  1/3/2017
Dayton NCORP
mi
from
Dayton, OH
Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors
Feasibility of Omega-3 Supplementation for Cancer-Related Fatigue
Status: Enrolling
Updated: 1/3/2017
Dayton NCORP
mi
from
Dayton, OH
Click here to add this to my saved trials
Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors
Feasibility of Omega-3 Supplementation for Cancer-Related Fatigue
Status: Enrolling
Updated:  1/3/2017
Greenville Health System NCORP
mi
from
Greenville, SC
Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors
Feasibility of Omega-3 Supplementation for Cancer-Related Fatigue
Status: Enrolling
Updated: 1/3/2017
Greenville Health System NCORP
mi
from
Greenville, SC
Click here to add this to my saved trials
Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors
Feasibility of Omega-3 Supplementation for Cancer-Related Fatigue
Status: Enrolling
Updated:  1/3/2017
Wisconsin NCORP
mi
from
Marshfield, WI
Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors
Feasibility of Omega-3 Supplementation for Cancer-Related Fatigue
Status: Enrolling
Updated: 1/3/2017
Wisconsin NCORP
mi
from
Marshfield, WI
Click here to add this to my saved trials
Randomized Amifostine For SCCHN
Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck
Status: Enrolling
Updated:  1/3/2017
Goodall Hospital
mi
from
Sanford, ME
Randomized Amifostine For SCCHN
Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck
Status: Enrolling
Updated: 1/3/2017
Goodall Hospital
mi
from
Sanford, ME
Click here to add this to my saved trials
Randomized Amifostine For SCCHN
Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck
Status: Enrolling
Updated:  1/3/2017
Massachusetts General Hospital
mi
from
Boston, MA
Randomized Amifostine For SCCHN
Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck
Status: Enrolling
Updated: 1/3/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Randomized Amifostine For SCCHN
Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck
Status: Enrolling
Updated:  1/3/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Randomized Amifostine For SCCHN
Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck
Status: Enrolling
Updated: 1/3/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Randomized Amifostine For SCCHN
Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck
Status: Enrolling
Updated:  1/3/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Randomized Amifostine For SCCHN
Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck
Status: Enrolling
Updated: 1/3/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Randomized Amifostine For SCCHN
Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck
Status: Enrolling
Updated:  1/3/2017
Bethke Cancer Center at Emerson Hospital
mi
from
Concord, MA
Randomized Amifostine For SCCHN
Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck
Status: Enrolling
Updated: 1/3/2017
Bethke Cancer Center at Emerson Hospital
mi
from
Concord, MA
Click here to add this to my saved trials
Randomized Amifostine For SCCHN
Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck
Status: Enrolling
Updated:  1/3/2017
Mass General/North Shore Cancer Center
mi
from
Danvers, MA
Randomized Amifostine For SCCHN
Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck
Status: Enrolling
Updated: 1/3/2017
Mass General/North Shore Cancer Center
mi
from
Danvers, MA
Click here to add this to my saved trials
Randomized Amifostine For SCCHN
Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck
Status: Enrolling
Updated:  1/3/2017
Saint Anne's Hospital - Fall River
mi
from
Fall River, MA
Randomized Amifostine For SCCHN
Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck
Status: Enrolling
Updated: 1/3/2017
Saint Anne's Hospital - Fall River
mi
from
Fall River, MA
Click here to add this to my saved trials
Randomized Amifostine For SCCHN
Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck
Status: Enrolling
Updated:  1/3/2017
Lowell General Hospital
mi
from
Lowell, MA
Randomized Amifostine For SCCHN
Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck
Status: Enrolling
Updated: 1/3/2017
Lowell General Hospital
mi
from
Lowell, MA
Click here to add this to my saved trials
Randomized Amifostine For SCCHN
Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck
Status: Enrolling
Updated:  1/3/2017
Wentworth-Douglass Hospital
mi
from
Dover, NH
Randomized Amifostine For SCCHN
Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck
Status: Enrolling
Updated: 1/3/2017
Wentworth-Douglass Hospital
mi
from
Dover, NH
Click here to add this to my saved trials
Exercise in Lessening Fatigue Caused by Cancer in Patients Undergoing Chemotherapy
A Study of the Effects of Exercise on Cancer-Related Fatigue
Status: Enrolling
Updated:  1/4/2017
James P. Wilmot Cancer Center at University of Rochester Medical Center
mi
from
Rochester, NY
Exercise in Lessening Fatigue Caused by Cancer in Patients Undergoing Chemotherapy
A Study of the Effects of Exercise on Cancer-Related Fatigue
Status: Enrolling
Updated: 1/4/2017
James P. Wilmot Cancer Center at University of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Impact of Atkinson Product Design Urinary Slide Valve Versus Standard Catheter Drainage System on Social Functioning
Impact of Atkinson Product Design Urinary Slide Valve Versus Standard Catheter Drainage System on Social Functioning
Status: Enrolling
Updated:  1/4/2017
Urology Associates
mi
from
Edina, MN
Impact of Atkinson Product Design Urinary Slide Valve Versus Standard Catheter Drainage System on Social Functioning
Impact of Atkinson Product Design Urinary Slide Valve Versus Standard Catheter Drainage System on Social Functioning
Status: Enrolling
Updated: 1/4/2017
Urology Associates
mi
from
Edina, MN
Click here to add this to my saved trials
Impact of Atkinson Product Design Urinary Slide Valve Versus Standard Catheter Drainage System on Social Functioning
Impact of Atkinson Product Design Urinary Slide Valve Versus Standard Catheter Drainage System on Social Functioning
Status: Enrolling
Updated:  1/4/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Impact of Atkinson Product Design Urinary Slide Valve Versus Standard Catheter Drainage System on Social Functioning
Impact of Atkinson Product Design Urinary Slide Valve Versus Standard Catheter Drainage System on Social Functioning
Status: Enrolling
Updated: 1/4/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions
Evaluation of [18F]PEB and Positron Emission Tomography (PET) as a Marker of mGluR5 in Subjects w/ Neuropsychiatric Conditions
Status: Enrolling
Updated:  1/5/2017
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions
Evaluation of [18F]PEB and Positron Emission Tomography (PET) as a Marker of mGluR5 in Subjects w/ Neuropsychiatric Conditions
Status: Enrolling
Updated: 1/5/2017
The Institute for Neurodegenerative Disorders
mi
from
New Haven, CT
Click here to add this to my saved trials
Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1
Pilot Study of Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1
Status: Enrolling
Updated:  1/9/2017
Massachusetts General Hospital
mi
from
Boston, MA
Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1
Pilot Study of Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1
Status: Enrolling
Updated: 1/9/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers
A Phase II, Randomized, Controlled, Two-Center Pilot Study of the Safety and Efficacy of Topically Applied MEBO® Wound Ointment Compared to Standard of Care in Subjects With Venous Leg Ulcers
Status: Enrolling
Updated:  1/10/2017
Center for Clinical Research
mi
from
Castro Valley, CA
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers
A Phase II, Randomized, Controlled, Two-Center Pilot Study of the Safety and Efficacy of Topically Applied MEBO® Wound Ointment Compared to Standard of Care in Subjects With Venous Leg Ulcers
Status: Enrolling
Updated: 1/10/2017
Center for Clinical Research
mi
from
Castro Valley, CA
Click here to add this to my saved trials
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers
A Phase II, Randomized, Controlled, Two-Center Pilot Study of the Safety and Efficacy of Topically Applied MEBO® Wound Ointment Compared to Standard of Care in Subjects With Venous Leg Ulcers
Status: Enrolling
Updated:  1/10/2017
University of Miami Miller School of Medicine
mi
from
Miami, FL
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers
A Phase II, Randomized, Controlled, Two-Center Pilot Study of the Safety and Efficacy of Topically Applied MEBO® Wound Ointment Compared to Standard of Care in Subjects With Venous Leg Ulcers
Status: Enrolling
Updated: 1/10/2017
University of Miami Miller School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic Study of GSK2881078 and Study to Evaluate the Effect of CYP3A4 Inhibition on PK of GSK2881078
A Randomized Double-blind (Sponsor Unblind) Placebo Controlled Study in Healthy Subjects to Evaluate: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Repeat Doses of GSK2881078, the Selective Androgen Receptor Modulator With an Open Label Dosing Arm to Evaluate the Effect of CYP3A4 Inhibition on Pharmacokinetics of GSK2881078
Status: Enrolling
Updated:  1/11/2017
GSK Investigational Site
mi
from
Overland Park, KA
Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic Study of GSK2881078 and Study to Evaluate the Effect of CYP3A4 Inhibition on PK of GSK2881078
A Randomized Double-blind (Sponsor Unblind) Placebo Controlled Study in Healthy Subjects to Evaluate: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Repeat Doses of GSK2881078, the Selective Androgen Receptor Modulator With an Open Label Dosing Arm to Evaluate the Effect of CYP3A4 Inhibition on Pharmacokinetics of GSK2881078
Status: Enrolling
Updated: 1/11/2017
GSK Investigational Site
mi
from
Overland Park, KA
Click here to add this to my saved trials
Study of Glutamate and Glutamine Metabolism in Burn Patients Receiving Enteral or Parenteral Nutrition
Study of Glutamate and Glutamine Metabolism in Burn Patients Receiving Enteral or Parenteral Nutrition
Status: Enrolling
Updated:  1/12/2017
Massachusetts General Hospital Burn Unit
mi
from
Boston, MA
Study of Glutamate and Glutamine Metabolism in Burn Patients Receiving Enteral or Parenteral Nutrition
Study of Glutamate and Glutamine Metabolism in Burn Patients Receiving Enteral or Parenteral Nutrition
Status: Enrolling
Updated: 1/12/2017
Massachusetts General Hospital Burn Unit
mi
from
Boston, MA
Click here to add this to my saved trials
Proline Metabolism in Severely Burned Patients: Effect of Modulated Parenteral Feeding
Proline Metabolism in Severely Burned Patients: Effect of Modulated Parenteral Feeding.
Status: Enrolling
Updated:  1/12/2017
Massachusetts General Hospital Burn Unit
mi
from
Boston, MA
Proline Metabolism in Severely Burned Patients: Effect of Modulated Parenteral Feeding
Proline Metabolism in Severely Burned Patients: Effect of Modulated Parenteral Feeding.
Status: Enrolling
Updated: 1/12/2017
Massachusetts General Hospital Burn Unit
mi
from
Boston, MA
Click here to add this to my saved trials
Glutamine Enriched Total Parenteral Feeding and Proline Metabolism in Severely Burned Patients
Glutamine Enriched Total Parenteral Feeding and Proline Metabolism in Severely Burned Patients.
Status: Enrolling
Updated:  1/12/2017
Massachusetts General Hospital Burn Unit
mi
from
Boston, MA
Glutamine Enriched Total Parenteral Feeding and Proline Metabolism in Severely Burned Patients
Glutamine Enriched Total Parenteral Feeding and Proline Metabolism in Severely Burned Patients.
Status: Enrolling
Updated: 1/12/2017
Massachusetts General Hospital Burn Unit
mi
from
Boston, MA
Click here to add this to my saved trials
Healing Touch in Treating Patients Receiving Chemotherapy for Acute Myeloid Leukemia or Acute Lymphocytic Leukemia
Healing Touch as a Supportive Intervention for Adult Acute Leukemia Patients: A Pilot Study
Status: Enrolling
Updated:  1/18/2017
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Healing Touch in Treating Patients Receiving Chemotherapy for Acute Myeloid Leukemia or Acute Lymphocytic Leukemia
Healing Touch as a Supportive Intervention for Adult Acute Leukemia Patients: A Pilot Study
Status: Enrolling
Updated: 1/18/2017
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer
Evaluation of a Yoga-Based Cancer Rehabilitation Program
Status: Enrolling
Updated:  1/23/2017
Albert Einstein College of Medicine
mi
from
Bronx, NY
Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer
Evaluation of a Yoga-Based Cancer Rehabilitation Program
Status: Enrolling
Updated: 1/23/2017
Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
Study to Compare Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media (AR01007)
A Phase 3, Multicenter, Placebo-controlled, Double-blind, Randomized Study to Compare the Efficacy and Safety of AR01 Otic Solution to a Placebo Solution for Relief of Pain in Acute Otitis Media Subjects Aged 2 Months to 19 Years
Status: Enrolling
Updated:  1/23/2017
Clinical Research Consortium - Arizona
mi
from
Phoenix, AZ
Study to Compare Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media (AR01007)
A Phase 3, Multicenter, Placebo-controlled, Double-blind, Randomized Study to Compare the Efficacy and Safety of AR01 Otic Solution to a Placebo Solution for Relief of Pain in Acute Otitis Media Subjects Aged 2 Months to 19 Years
Status: Enrolling
Updated: 1/23/2017
Clinical Research Consortium - Arizona
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study to Compare Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media (AR01007)
A Phase 3, Multicenter, Placebo-controlled, Double-blind, Randomized Study to Compare the Efficacy and Safety of AR01 Otic Solution to a Placebo Solution for Relief of Pain in Acute Otitis Media Subjects Aged 2 Months to 19 Years
Status: Enrolling
Updated:  1/23/2017
Pioneer Clinical Research, LLC
mi
from
Bellevue, NE
Study to Compare Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media (AR01007)
A Phase 3, Multicenter, Placebo-controlled, Double-blind, Randomized Study to Compare the Efficacy and Safety of AR01 Otic Solution to a Placebo Solution for Relief of Pain in Acute Otitis Media Subjects Aged 2 Months to 19 Years
Status: Enrolling
Updated: 1/23/2017
Pioneer Clinical Research, LLC
mi
from
Bellevue, NE
Click here to add this to my saved trials